PF-AKT400
PF-AKT400 is a potent, ATP-competitive small molecule inhibitor with broad selectivity for the Akt kinase family. It is widely used in preclinical research to investigate the PI3K/Akt signaling pathway in cancer biology, supporting both in vitro cellular assays and in vivo tumor model studies.
Product Specifications
CAS Number
1004990-28-6
Product Name Alternative
Akt, AKT protein kinase inhibitor, inhibit, Inhibitor, Protein kinase B, PF AKT400, PF-AKT 400, PFAKT400, PF-AKT400, PF-AKT-400, PKB
Field of Research
Signal Transduction
Purity
98.21% (May vary between batches)
Solubility
DMSO:90 mg/mL (224.76 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.24 mM)
Smiles
CCc1c[nH]c2ncnc (N3CC[C@] (N) (CNC (=O) c4ccc (F) cc4F) C3) c12
Molecular Formula
C20H22F2N6O
Molecular Weight
400.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1882360-01 0.01 mg
Biotinylated Anti-NCR1 antibody (2C10), IgG1 Chimeric mAb
Sign In for Pricing
View Details MBS1882360-02 0.1 mg
Biotinylated Anti-NCR1 antibody (2C10), IgG1 Chimeric mAb
Sign In for Pricing
View Details MBS1882360-03 0.5 mg
Biotinylated Anti-NCR1 antibody (2C10), IgG1 Chimeric mAb
Sign In for Pricing
View Details MBS1882360-04 5x 0.5 mg
Biotinylated Anti-NCR1 antibody (2C10), IgG1 Chimeric mAb
Sign In for Pricing
View Details 